Department of Plastic Surgery, Vanderbilt School of Medicine, Nashville, TN, USA.
J Plast Reconstr Aesthet Surg. 2013 Jul;66(7):917-25. doi: 10.1016/j.bjps.2013.03.009. Epub 2013 Apr 4.
There is a paucity of multi-institutional data that directly compares short term outcomes of autologous and prosthetic breast reconstruction. The National Surgical Quality Improvement Program provides a unique data platform for evaluating peri-operative outcomes of these two main categories of breast reconstruction. It has detailed data from nearly 250 hospitals and over 13,000 patients. We performed risk-adjusted analysis of prosthetic and autologous breast reconstruction to compare 30-day morbidity outcomes.
Patients who underwent prosthetic breast reconstruction or autologous tissue reconstruction from 2006 to 2010 were identified using operation descriptions. Over 240 tracked variables were extracted for patients undergoing breast reconstruction. Thirty-day postoperative outcomes were compared, and subgroup analysis was performed on the autologous population to describe outcomes of specific flap procedures. Reconstruction was analyzed as an independent risk factor for specific complications, with propensity scores used to help standardize compared patient populations. Regression analyses were performed using SPSS (version 20.0, Chicago, IL).
A total of 13,082 patients underwent breast reconstruction; 9786 patients received prosthetic reconstruction and 3296 received autologous reconstruction. Within the autologous cohort, 1608 (48.8%) patients underwent a pedicle TRAM flap, 1079 (32.7%) had a LD flap, and 609 (18.5%) received a free flap. Autologous reconstruction patients had higher rates of overall complications (12.47% vs 5.38%, p<.001), wound infection (5.46% vs 3.45%, p<.001), prosthesis/flap failure (3.13% vs 0.85%, p<.001), and reoperation (9.59% vs 6.76%, p<.001). Risk-adjusted multivariate analysis also showed autologous reconstruction to be a significant independent predictor of specific short term outcomes.
Using risk-adjusted models of a large multi-institutional database, we found that--relative to prosthetic reconstruction--autologous reconstruction had higher rates of 30-day overall complications, wound infection, prosthesis/flap failure, and reoperation. This may be due, in part, to a concomitant increase in operative time and higher case complexity. Taken with other reports such as NMBRA, this study helps to educate patients and surgeons alike on potential, comparative complications during the perioperative period.
目前鲜有直接比较自体和假体乳房重建短期结果的多机构数据。国家外科质量改进计划(National Surgical Quality Improvement Program)为评估这两种主要乳房重建类别的围手术期结果提供了独特的数据平台。该计划详细记录了近 250 家医院和 13000 多名患者的数据。我们对假体和自体乳房重建进行了风险调整分析,以比较 30 天发病率结果。
使用手术描述识别 2006 年至 2010 年期间接受假体乳房重建或自体组织重建的患者。从接受乳房重建的患者中提取了 240 多个跟踪变量。比较 30 天术后结果,并对自体人群进行亚组分析以描述特定皮瓣手术的结果。将重建作为特定并发症的独立危险因素进行分析,并使用倾向评分帮助标准化比较患者人群。使用 SPSS(版本 20.0,芝加哥,IL)进行回归分析。
共有 13082 名患者接受了乳房重建;9786 名患者接受了假体重建,3296 名患者接受了自体重建。在自体队列中,1608 名(48.8%)患者接受了带蒂横形腹直肌肌皮瓣(TRAM)皮瓣,1079 名(32.7%)患者接受了下腹部皮瓣(LD)皮瓣,609 名(18.5%)患者接受了游离皮瓣。自体重建患者的总体并发症发生率较高(12.47%比 5.38%,p<.001),包括伤口感染(5.46%比 3.45%,p<.001)、假体/皮瓣失败(3.13%比 0.85%,p<.001)和再次手术(9.59%比 6.76%,p<.001)。多变量风险调整分析还表明,自体重建是特定短期结果的显著独立预测因素。
使用大型多机构数据库的风险调整模型,我们发现与假体重建相比,自体重建的 30 天总体并发症、伤口感染、假体/皮瓣失败和再次手术的发生率更高。这可能部分归因于手术时间的增加和手术复杂性的增加。与 NMBRA 等其他报告一起,本研究有助于教育患者和外科医生在围手术期可能出现的、具有可比性的并发症。